Senior insider sale
Chief Financial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$692.6K
41.71K shares
What this filing means
GRUBER JAMES R. plans to sell 41.71K shares of ETON PHARMACEUTICALS, INC. valued at approximately $692.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2025ACC: 0001974078-25-000267
Officer· Chief Financial Officer
Since Apr 2022
41.71K
Shares to sell
$692.6K
Approx. market value
41.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
ESPP
Payroll
12/10/2024
3.25KGrant
Grant
7/12/2024
10KESPP
Payroll
6/10/2024
5.86KESPP
Payroll
12/10/2023
3.15KGrant
Grant
7/12/2023
10KESPP
Payroll
6/9/2023
5.86KESPP
Payroll
12/9/2022
3.60KTotal acquired41.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | ESPP Payroll | 3.25K | — |
7/12/2024 | Grant Grant | 10K | — |
6/10/2024 | ESPP Payroll | 5.86K | — |
12/10/2023 | ESPP Payroll | 3.15K | — |
7/12/2023 | Grant Grant | 10K | — |
6/9/2023 | ESPP Payroll | 5.86K | — |
12/9/2022 | ESPP Payroll | 3.60K | — |
| Total | 41.71K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
41.71K
Market value
$692.6K
8/18/2025
Total
Units
41.71K
Value
$692.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2025 | 41.71K | $692.6K | NASDAQ | Planned |
| Total | 41.71K | $692.6K | ||